NEW content online! Lactate promotes DNA repair dlvr.it/TBXp6r

Exploring the intersection of cancer & pregnancy, a study in Cell highlights how both conditions utilize similar immune tolerance mechanisms. For more details, check out our Research Highlight now: go.nature.com/3SCmqIZ

In case you missed it... Our latest poster (in collaboration with Nature Rev Immunol), from Daniel Peeper & Daniela Thommen, explores how to boost anti-tumour immunity by combining #PD1 axis blockade with other cancer therapies. Check it out now! go.nature.com/3WLcCh5

NEW content online! Tertiary lymphoid structures in anticancer immunity dlvr.it/TBh6fM

Metabolites that accumulate in tumours due to altered metabolism can limit DNA repair. Now in nature, Behrens lab, Yin lab & Zhang lab, find lactate promotes homologous recombination-mediated DNA repair & resistance to DNA-damaging chemotherapy. 🖱️go.nature.com/3yBhwoy

NEW content online! Tracing the evolutionary history of breast cancer dlvr.it/TBwrDl

Tertiary lymphoid structures (TLS) are found in many solid tumours. In this Review, the Dieu-Nosjean group (Sorbonne Université), highlight the unique biology of TLS & their potential for therapeutic targeting to orchestrate immune responses. 📖it➡️go.nature.com/3YFus7s

NEW content online! Integrative medicine in oncology: redefining the standard of care dlvr.it/TC1fPs

so grateful for the opportunity to highlight our work on multiplexed transcriptome engineering & combinatorial screening for better CAR T cell therapies in the latest issue of Nature Reviews Cancer!! 📄: rdcu.be/dHbjn

NEW content online! Thelpers? More like Ttroublemakers dlvr.it/TC739Z

Despite its benefits, #integrativeoncology is challenged by inconsistent healthcare coverage & limited access. In this #Comment, Lorenzo Cohen, Santhosshi Narayanan, MD FACP & Gabriel Lopez emphasize the need for addressing these barriers to improve patient outcomes. 🐁➡️go.nature.com/4dRd3xd

Check out our most recent #JournalClub from Jiwon Koh & Seock-Ah Im (Seoul National University Hospital), demonstrating the unique evolutionary trajectory of breast cancers harbouring the common driver alteration der(1;16). Linked here 👇 go.nature.com/3WPRTsb

NEW content online! Limiting bias in AI models for improved and equitable cancer care dlvr.it/TCSRLK

Our Editor, Daniela Senft Daniela Senft is attending the #FrankfurtCancerConference. If you are here Goethe-Universität and want to chat - please come up and say hi. frankfurtcancerconference.org

NEW content online! Targeting the tumour vasculature: from vessel destruction to promotion dlvr.it/TCY0PV

NEW content online! Author Correction: Integrative medicine in oncology: redefining the standard of care dlvr.it/TCY0Q5

NEW content online! Cancer drug-tolerant persister cells: from biological questions to clinical opportunities dlvr.it/TCljVQ

📢This week in Nature Reviews Cancer, a joint effort by many groups led by the Bardelli Lab on #Cancer Persister cells. 🙌🏻It’s been a pleasure to contribute to this roadmap. ➡️rdcu.be/dSJp4

In case you missed it: Marzyeh (MIT IMES,MIT EECS) and Alexander Gusev (Dana-Farber) comment on limiting bias in AI models for improved and equitable cancer care. Check it out: go.nature.com/3TdcndB